isco logo.jpg
International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019
May 17, 2019 08:30 ET | International Stem Cell Corporation
CARLSBAD, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
isco logo.jpg
International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results
April 15, 2019 08:30 ET | International Stem Cell Corporation
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
isco logo.jpg
International Stem Cell Corporation Commences Trading on the OTCQX Best Market
March 04, 2019 07:00 ET | International Stem Cell Corporation
CARLSBAD, Calif., March 04, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQX:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
isco logo.jpg
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
February 13, 2019 08:30 ET | International Stem Cell Corporation
CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
isco logo.jpg
International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program
August 21, 2018 07:00 ET | International Stem Cell Corporation
CARLSBAD, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
isco logo.jpg
International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products
July 10, 2018 07:00 ET | International Stem Cell Corporation
CARLSBAD, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing...
isco logo.jpg
International Stem Cell Corporation to Launch Advanced Joint Supplement
June 05, 2018 07:00 ET | International Stem Cell Corporation
CARLSBAD, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
November 29, 2017 08:30 ET | International Stem Cell Corporation
CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage...